[{"NetIncomeLoss_1_Q3_USD":-55690.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q3_USD":7520000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":21320000.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":150000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":262636479.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":26255311.0,"AssetsCurrent_0_Q3_USD":1222328.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-276000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":8061050.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":6869801.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":150000.0,"Liabilities_0_Q3_USD":9723485.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1140963.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-130771.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-131771.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":7520000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":671828.0,"TemporaryEquityNetIncome_1_Q3_USD":-75081.0,"TemporaryEquityNetIncome_3_Q3_USD":-75081.0,"CostsAndExpenses_1_Q3_USD":184615.0,"CostsAndExpenses_3_Q3_USD":185615.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":277353172.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":276137639.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":8714.0,"IncomeTaxExpenseBenefit_3_Q3_USD":8714.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":54771.0,"Assets_0_Q3_USD":277359967.0,"PrepaidExpenseCurrent_0_Q3_USD":81365.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":41496.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"NetIncomeLoss_3_Q3_USD":-56690.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":8714.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":5055869.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1140963.0,"NonoperatingIncomeExpense_1_Q3_USD":137639.0,"NonoperatingIncomeExpense_3_Q3_USD":137639.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-212209.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-46976.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-47976.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":1140963.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-56690.0,"StockholdersEquity_0_Q3_USD":5000003.0,"ProfitLoss_3_Q3_USD":-56690.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.02,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.02,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":7520000.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":277359967.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":8714.0,"PreferredStockValue_0_Q3_USD":null,"InvestmentIncomeInterest_1_Q3_USD":96143.0,"InvestmentIncomeInterest_3_Q3_USD":96143.0,"OperatingIncomeLoss_1_Q3_USD":-184615.0,"OperatingIncomeLoss_3_Q3_USD":-185615.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":25000.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":41496.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":81365.0,"Ticker":"GLS","CIK":"1805087","name":"CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.","OfficialName":"Gelesis Holdings Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"341682749.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NYSE","SP500":"nan","filed":"20201113"}]